SUGP2_HUMAN - dbPTM
SUGP2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SUGP2_HUMAN
UniProt AC Q8IX01
Protein Name SURP and G-patch domain-containing protein 2
Gene Name SUGP2
Organism Homo sapiens (Human).
Sequence Length 1082
Subcellular Localization Nucleus .
Protein Description May play a role in mRNA splicing..
Protein Sequence MAARRITQETFDAVLQEKAKRYHMDASGEAVSETLQFKAQDLLRAVPRSRAEMYDDVHSDGRYSLSGSVAHSRDAGREGLRSDVFPGPSFRSSNPSISDDSYFRKECGRDLEFSHSDSRDQVIGHRKLGHFRSQDWKFALRGSWEQDFGHPVSQESSWSQEYSFGPSAVLGDFGSSRLIEKECLEKESRDYDVDHPGEADSVLRGGSQVQARGRALNIVDQEGSLLGKGETQGLLTAKGGVGKLVTLRNVSTKKIPTVNRITPKTQGTNQIQKNTPSPDVTLGTNPGTEDIQFPIQKIPLGLDLKNLRLPRRKMSFDIIDKSDVFSRFGIEIIKWAGFHTIKDDIKFSQLFQTLFELETETCAKMLASFKCSLKPEHRDFCFFTIKFLKHSALKTPRVDNEFLNMLLDKGAVKTKNCFFEIIKPFDKYIMRLQDRLLKSVTPLLMACNAYELSVKMKTLSNPLDLALALETTNSLCRKSLALLGQTFSLASSFRQEKILEAVGLQDIAPSPAAFPNFEDSTLFGREYIDHLKAWLVSSGCPLQVKKAEPEPMREEEKMIPPTKPEIQAKAPSSLSDAVPQRADHRVVGTIDQLVKRVIEGSLSPKERTLLKEDPAYWFLSDENSLEYKYYKLKLAEMQRMSENLRGADQKPTSADCAVRAMLYSRAVRNLKKKLLPWQRRGLLRAQGLRGWKARRATTGTQTLLSSGTRLKHHGRQAPGLSQAKPSLPDRNDAAKDCPPDPVGPSPQDPSLEASGPSPKPAGVDISEAPQTSSPCPSADIDMKTMETAEKLARFVAQVGPEIEQFSIENSTDNPDLWFLHDQNSSAFKFYRKKVFELCPSICFTSSPHNLHTGGGDTTGSQESPVDLMEGEAEFEDEPPPREAELESPEVMPEEEDEDDEDGGEEAPAPGGAGKSEGSTPADGLPGEAAEDDLAGAPALSQASSGTCFPRKRISSKSLKVGMIPAPKRVCLIQEPKVHEPVRIAYDRPRGRPMSKKKKPKDLDFAQQKLTDKNLGFQMLQKMGWKEGHGLGSLGKGIREPVSVGTPSEGEGLGADGQEHKEDTFDVFRQRMMQMYRHKRANK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
7Phosphorylation-MAARRITQETFDAV
-CCCHHHCHHHHHHH
20.6717525332
10PhosphorylationARRITQETFDAVLQE
CHHHCHHHHHHHHHH
19.5928450419
18UbiquitinationFDAVLQEKAKRYHMD
HHHHHHHHHHHHCCC
46.37-
38UbiquitinationVSETLQFKAQDLLRA
HHHHHHHHHHHHHHH
31.98-
49O-linked_GlycosylationLLRAVPRSRAEMYDD
HHHHCCHHHHHHHCC
29.7630379171
49PhosphorylationLLRAVPRSRAEMYDD
HHHHCCHHHHHHHCC
29.7621945579
54PhosphorylationPRSRAEMYDDVHSDG
CHHHHHHHCCCCCCC
10.6621945579
59PhosphorylationEMYDDVHSDGRYSLS
HHHCCCCCCCCEEEC
41.4221945579
63PhosphorylationDVHSDGRYSLSGSVA
CCCCCCCEEECCCEE
21.3521945579
64PhosphorylationVHSDGRYSLSGSVAH
CCCCCCEEECCCEEE
18.0721945579
66PhosphorylationSDGRYSLSGSVAHSR
CCCCEEECCCEEECC
24.0721945579
68PhosphorylationGRYSLSGSVAHSRDA
CCEEECCCEEECCCC
16.8621945579
72PhosphorylationLSGSVAHSRDAGREG
ECCCEEECCCCCCCC
23.3221945579
82PhosphorylationAGREGLRSDVFPGPS
CCCCCCCCCCCCCCC
43.0720068231
89PhosphorylationSDVFPGPSFRSSNPS
CCCCCCCCCCCCCCC
38.9327499020
92PhosphorylationFPGPSFRSSNPSISD
CCCCCCCCCCCCCCC
32.2423401153
93PhosphorylationPGPSFRSSNPSISDD
CCCCCCCCCCCCCCC
48.8021815630
96PhosphorylationSFRSSNPSISDDSYF
CCCCCCCCCCCCHHH
38.6921815630
98PhosphorylationRSSNPSISDDSYFRK
CCCCCCCCCCHHHHH
39.4427732954
101PhosphorylationNPSISDDSYFRKECG
CCCCCCCHHHHHHHC
31.0327732954
102PhosphorylationPSISDDSYFRKECGR
CCCCCCHHHHHHHCC
17.8827732954
114PhosphorylationCGRDLEFSHSDSRDQ
HCCCCCCCCCCCCCC
16.8330266825
116PhosphorylationRDLEFSHSDSRDQVI
CCCCCCCCCCCCCEE
35.7630266825
118PhosphorylationLEFSHSDSRDQVIGH
CCCCCCCCCCCEECC
40.5530266825
127UbiquitinationDQVIGHRKLGHFRSQ
CCEECCCCCCCCCCC
53.82-
133PhosphorylationRKLGHFRSQDWKFAL
CCCCCCCCCCCCEEE
31.3927067055
137UbiquitinationHFRSQDWKFALRGSW
CCCCCCCCEEECCCH
29.1121890473
137UbiquitinationHFRSQDWKFALRGSW
CCCCCCCCEEECCCH
29.1121890473
137 (in isoform 1)Ubiquitination-29.1121890473
137 (in isoform 3)Ubiquitination-29.1121890473
137 (in isoform 4)Ubiquitination-29.1121890473
143PhosphorylationWKFALRGSWEQDFGH
CCEEECCCHHCCCCC
22.4727251275
153PhosphorylationQDFGHPVSQESSWSQ
CCCCCCCCCCCCCCC
32.4528348404
156PhosphorylationGHPVSQESSWSQEYS
CCCCCCCCCCCCEEC
29.4827251275
157PhosphorylationHPVSQESSWSQEYSF
CCCCCCCCCCCEECC
29.9627251275
159PhosphorylationVSQESSWSQEYSFGP
CCCCCCCCCEECCCC
18.3227251275
162PhosphorylationESSWSQEYSFGPSAV
CCCCCCEECCCCCHH
11.1528464451
181UbiquitinationGSSRLIEKECLEKES
CCHHHHHHHHHHHHC
46.89-
186AcetylationIEKECLEKESRDYDV
HHHHHHHHHCCCCCC
48.3026051181
186UbiquitinationIEKECLEKESRDYDV
HHHHHHHHHCCCCCC
48.30-
201PhosphorylationDHPGEADSVLRGGSQ
CCCCCHHHHHCCCCC
30.0520873877
204MethylationGEADSVLRGGSQVQA
CCHHHHHCCCCCHHH
45.32115916669
212MethylationGGSQVQARGRALNIV
CCCCHHHCCCEEEEE
20.3183435591
214MethylationSQVQARGRALNIVDQ
CCHHHCCCEEEEECC
30.28115916673
224PhosphorylationNIVDQEGSLLGKGET
EEECCCCCCCCCCCC
21.4830266825
228AcetylationQEGSLLGKGETQGLL
CCCCCCCCCCCCCCE
54.2526051181
228SumoylationQEGSLLGKGETQGLL
CCCCCCCCCCCCCCE
54.2528112733
228UbiquitinationQEGSLLGKGETQGLL
CCCCCCCCCCCCCCE
54.25-
238AcetylationTQGLLTAKGGVGKLV
CCCCEEECCCCCEEE
51.4625953088
238UbiquitinationTQGLLTAKGGVGKLV
CCCCEEECCCCCEEE
51.46-
243AcetylationTAKGGVGKLVTLRNV
EECCCCCEEEEEECC
37.0625953088
243UbiquitinationTAKGGVGKLVTLRNV
EECCCCCEEEEEECC
37.06-
251PhosphorylationLVTLRNVSTKKIPTV
EEEEECCCCCCCCCC
37.7526074081
252PhosphorylationVTLRNVSTKKIPTVN
EEEECCCCCCCCCCC
31.8826074081
257PhosphorylationVSTKKIPTVNRITPK
CCCCCCCCCCCCCCC
33.6128555341
262PhosphorylationIPTVNRITPKTQGTN
CCCCCCCCCCCCCCC
18.5925159151
264SumoylationTVNRITPKTQGTNQI
CCCCCCCCCCCCCCC
44.84-
264SumoylationTVNRITPKTQGTNQI
CCCCCCCCCCCCCCC
44.84-
264UbiquitinationTVNRITPKTQGTNQI
CCCCCCCCCCCCCCC
44.84-
265PhosphorylationVNRITPKTQGTNQIQ
CCCCCCCCCCCCCCC
33.1729449344
268PhosphorylationITPKTQGTNQIQKNT
CCCCCCCCCCCCCCC
17.7128450419
273UbiquitinationQGTNQIQKNTPSPDV
CCCCCCCCCCCCCCC
65.50-
275PhosphorylationTNQIQKNTPSPDVTL
CCCCCCCCCCCCCCC
31.9830266825
275 (in isoform 3)Phosphorylation-31.98-
277PhosphorylationQIQKNTPSPDVTLGT
CCCCCCCCCCCCCCC
31.5225159151
277 (in isoform 3)Phosphorylation-31.52-
281PhosphorylationNTPSPDVTLGTNPGT
CCCCCCCCCCCCCCC
27.1830266825
284PhosphorylationSPDVTLGTNPGTEDI
CCCCCCCCCCCCCCC
41.1630278072
288PhosphorylationTLGTNPGTEDIQFPI
CCCCCCCCCCCCCCH
31.5723403867
297UbiquitinationDIQFPIQKIPLGLDL
CCCCCHHHCCCCCCC
47.19-
305UbiquitinationIPLGLDLKNLRLPRR
CCCCCCCCCCCCCCC
54.3121890473
305SumoylationIPLGLDLKNLRLPRR
CCCCCCCCCCCCCCC
54.3128112733
305UbiquitinationIPLGLDLKNLRLPRR
CCCCCCCCCCCCCCC
54.3121890473
305 (in isoform 1)Ubiquitination-54.3121890473
305 (in isoform 3)Ubiquitination-54.3121890473
305 (in isoform 4)Ubiquitination-54.3121890473
313UbiquitinationNLRLPRRKMSFDIID
CCCCCCCCCEEEEEC
39.93-
315PhosphorylationRLPRRKMSFDIIDKS
CCCCCCCEEEEECHH
23.8525159151
315 (in isoform 3)Phosphorylation-23.85-
321UbiquitinationMSFDIIDKSDVFSRF
CEEEEECHHHHHHHH
37.84-
322PhosphorylationSFDIIDKSDVFSRFG
EEEEECHHHHHHHHH
34.9520068231
326PhosphorylationIDKSDVFSRFGIEII
ECHHHHHHHHHHEEH
26.9220068231
342AcetylationWAGFHTIKDDIKFSQ
ECCCCCCCCCCCHHH
50.9726051181
342UbiquitinationWAGFHTIKDDIKFSQ
ECCCCCCCCCCCHHH
50.97-
348PhosphorylationIKDDIKFSQLFQTLF
CCCCCCHHHHHHHHH
22.44-
368PhosphorylationTCAKMLASFKCSLKP
HHHHHHHHCCCCCCH
22.6824719451
370UbiquitinationAKMLASFKCSLKPEH
HHHHHHCCCCCCHHH
22.03-
389UbiquitinationFFTIKFLKHSALKTP
EEHHHHHHHHCCCCC
38.35-
391PhosphorylationTIKFLKHSALKTPRV
HHHHHHHHCCCCCCC
33.4428348404
394UbiquitinationFLKHSALKTPRVDNE
HHHHHCCCCCCCCHH
57.08-
395PhosphorylationLKHSALKTPRVDNEF
HHHHCCCCCCCCHHH
19.7128348404
409UbiquitinationFLNMLLDKGAVKTKN
HHHHHHHCCCCCCCC
49.06-
415UbiquitinationDKGAVKTKNCFFEII
HCCCCCCCCCCEEEC
46.10-
423UbiquitinationNCFFEIIKPFDKYIM
CCCEEECCHHHHHHH
45.34-
427UbiquitinationEIIKPFDKYIMRLQD
EECCHHHHHHHHHHH
36.7421890473
427UbiquitinationEIIKPFDKYIMRLQD
EECCHHHHHHHHHHH
36.7421890473
427 (in isoform 1)Ubiquitination-36.7421890473
427 (in isoform 3)Ubiquitination-36.7421890473
427 (in isoform 4)Ubiquitination-36.7421890473
428PhosphorylationIIKPFDKYIMRLQDR
ECCHHHHHHHHHHHH
11.20-
439PhosphorylationLQDRLLKSVTPLLMA
HHHHHHHHHHHHHHH
31.0626261332
441PhosphorylationDRLLKSVTPLLMACN
HHHHHHHHHHHHHHC
18.4726261332
450PhosphorylationLLMACNAYELSVKMK
HHHHHCHHHHHCCEE
11.9226261332
453PhosphorylationACNAYELSVKMKTLS
HHCHHHHHCCEECCC
14.0426261332
458PhosphorylationELSVKMKTLSNPLDL
HHHCCEECCCCHHHH
31.74-
478UbiquitinationTTNSLCRKSLALLGQ
HHHHHHHHHHHHHHH
49.15-
479PhosphorylationTNSLCRKSLALLGQT
HHHHHHHHHHHHHHH
10.2620068231
492PhosphorylationQTFSLASSFRQEKIL
HHHHHHHHHCHHHHH
20.8820068231
510PhosphorylationGLQDIAPSPAAFPNF
CCCCCCCCCCCCCCC
20.39-
532UbiquitinationREYIDHLKAWLVSSG
HHHHHHHHHHHHHCC
33.81-
537PhosphorylationHLKAWLVSSGCPLQV
HHHHHHHHCCCCCEE
20.8824425749
538PhosphorylationLKAWLVSSGCPLQVK
HHHHHHHCCCCCEEE
36.6124425749
545AcetylationSGCPLQVKKAEPEPM
CCCCCEEECCCCCCC
33.0525953088
545UbiquitinationSGCPLQVKKAEPEPM
CCCCCEEECCCCCCC
33.05-
546AcetylationGCPLQVKKAEPEPMR
CCCCEEECCCCCCCC
60.1626051181
546UbiquitinationGCPLQVKKAEPEPMR
CCCCEEECCCCCCCC
60.16-
557AcetylationEPMREEEKMIPPTKP
CCCCHHHHCCCCCCH
45.477692163
562PhosphorylationEEKMIPPTKPEIQAK
HHHCCCCCCHHHHHC
54.60-
563AcetylationEKMIPPTKPEIQAKA
HHCCCCCCHHHHHCC
46.567692171
572PhosphorylationEIQAKAPSSLSDAVP
HHHHCCCCCHHHHCC
49.0930266825
573PhosphorylationIQAKAPSSLSDAVPQ
HHHCCCCCHHHHCCC
30.7330266825
575PhosphorylationAKAPSSLSDAVPQRA
HCCCCCHHHHCCCCC
26.0230266825
595UbiquitinationGTIDQLVKRVIEGSL
CCHHHHHHHHHHCCC
49.9221890473
595UbiquitinationGTIDQLVKRVIEGSL
CCHHHHHHHHHHCCC
49.9221890473
595 (in isoform 1)Ubiquitination-49.9221890473
595 (in isoform 3)Ubiquitination-49.9221890473
595 (in isoform 4)Ubiquitination-49.9221890473
601PhosphorylationVKRVIEGSLSPKERT
HHHHHHCCCCHHHHH
16.9430266825
603PhosphorylationRVIEGSLSPKERTLL
HHHHCCCCHHHHHCC
35.3130266825
605AcetylationIEGSLSPKERTLLKE
HHCCCCHHHHHCCCC
57.3523749302
605UbiquitinationIEGSLSPKERTLLKE
HHCCCCHHHHHCCCC
57.35-
611UbiquitinationPKERTLLKEDPAYWF
HHHHHCCCCCCCCEE
64.28-
633UbiquitinationEYKYYKLKLAEMQRM
HHHHHHHHHHHHHHH
41.31-
641PhosphorylationLAEMQRMSENLRGAD
HHHHHHHHHHHCCCC
26.0624719451
650SumoylationNLRGADQKPTSADCA
HHCCCCCCCCHHHHH
51.3028112733
650UbiquitinationNLRGADQKPTSADCA
HHCCCCCCCCHHHHH
51.30-
664PhosphorylationAVRAMLYSRAVRNLK
HHHHHHHHHHHHHHH
15.1424719451
673UbiquitinationAVRNLKKKLLPWQRR
HHHHHHHHHCHHHHH
54.3821890473
673UbiquitinationAVRNLKKKLLPWQRR
HHHHHHHHHCHHHHH
54.382189047
673 (in isoform 1)Ubiquitination-54.3821890473
673 (in isoform 3)Ubiquitination-54.3821890473
673 (in isoform 4)Ubiquitination-54.3821890473
689MethylationLLRAQGLRGWKARRA
HHHHHCCCCHHHEEC
56.61115916677
697PhosphorylationGWKARRATTGTQTLL
CHHHEECCCCCHHHH
24.7728555341
705PhosphorylationTGTQTLLSSGTRLKH
CCCHHHHHCCCCCCC
29.8126462736
706PhosphorylationGTQTLLSSGTRLKHH
CCHHHHHCCCCCCCC
44.1228674419
708PhosphorylationQTLLSSGTRLKHHGR
HHHHHCCCCCCCCCC
34.47-
721PhosphorylationGRQAPGLSQAKPSLP
CCCCCCCCCCCCCCC
33.7223312004
724AcetylationAPGLSQAKPSLPDRN
CCCCCCCCCCCCCCC
27.7426051181
726PhosphorylationGLSQAKPSLPDRNDA
CCCCCCCCCCCCCCH
52.4024719451
745PhosphorylationPPDPVGPSPQDPSLE
CCCCCCCCCCCCCCC
29.3025159151
745 (in isoform 3)Phosphorylation-29.30-
750PhosphorylationGPSPQDPSLEASGPS
CCCCCCCCCCCCCCC
47.3230266825
754PhosphorylationQDPSLEASGPSPKPA
CCCCCCCCCCCCCCC
41.6930266825
757PhosphorylationSLEASGPSPKPAGVD
CCCCCCCCCCCCCCC
49.4330266825
766PhosphorylationKPAGVDISEAPQTSS
CCCCCCHHHCCCCCC
24.2030206219
771PhosphorylationDISEAPQTSSPCPSA
CHHHCCCCCCCCCCC
30.0725159151
772PhosphorylationISEAPQTSSPCPSAD
HHHCCCCCCCCCCCC
27.3425159151
773PhosphorylationSEAPQTSSPCPSADI
HHCCCCCCCCCCCCC
33.6325159151
777PhosphorylationQTSSPCPSADIDMKT
CCCCCCCCCCCCHHH
45.3425159151
790UbiquitinationKTMETAEKLARFVAQ
HHHHHHHHHHHHHHH
45.01-
806PhosphorylationGPEIEQFSIENSTDN
CCHHEEEEEECCCCC
28.78-
810PhosphorylationEQFSIENSTDNPDLW
EEEEEECCCCCCCCE
25.09-
811PhosphorylationQFSIENSTDNPDLWF
EEEEECCCCCCCCEE
51.91-
824PhosphorylationWFLHDQNSSAFKFYR
EEEECCCCCHHHHHH
19.8725627689
825PhosphorylationFLHDQNSSAFKFYRK
EEECCCCCHHHHHHH
45.3225627689
840PhosphorylationKVFELCPSICFTSSP
HHHHHCCHHHCCCCC
30.8726074081
844PhosphorylationLCPSICFTSSPHNLH
HCCHHHCCCCCCCCC
24.7126074081
845PhosphorylationCPSICFTSSPHNLHT
CCHHHCCCCCCCCCC
22.9426074081
846PhosphorylationPSICFTSSPHNLHTG
CHHHCCCCCCCCCCC
27.4126074081
852PhosphorylationSSPHNLHTGGGDTTG
CCCCCCCCCCCCCCC
40.4626074081
857PhosphorylationLHTGGGDTTGSQESP
CCCCCCCCCCCCCCC
36.0126074081
858PhosphorylationHTGGGDTTGSQESPV
CCCCCCCCCCCCCCC
39.3126074081
860PhosphorylationGGGDTTGSQESPVDL
CCCCCCCCCCCCCCC
28.7826074081
863PhosphorylationDTTGSQESPVDLMEG
CCCCCCCCCCCCCCC
23.6826074081
887PhosphorylationPREAELESPEVMPEE
CCHHCCCCCCCCCCC
38.7030278072
919O-linked_GlycosylationAGKSEGSTPADGLPG
CCCCCCCCCCCCCCC
33.0930379171
940O-linked_GlycosylationLAGAPALSQASSGTC
CCCCCHHHHCCCCCC
26.3030379171
940PhosphorylationLAGAPALSQASSGTC
CCCCCHHHHCCCCCC
26.3017525332
955PhosphorylationFPRKRISSKSLKVGM
CCCCCCCCCCEEECC
24.7226434776
957PhosphorylationRKRISSKSLKVGMIP
CCCCCCCCEEECCCC
35.0626434776
985PhosphorylationHEPVRIAYDRPRGRP
CCCEECEEECCCCCC
15.3225884760
1008UbiquitinationDLDFAQQKLTDKNLG
CCCHHHHHHCCCHHH
41.07-
1012UbiquitinationAQQKLTDKNLGFQML
HHHHHCCCHHHHHHH
49.16-
1021MethylationLGFQMLQKMGWKEGH
HHHHHHHHHCCCCCC
35.10115981369
1025UbiquitinationMLQKMGWKEGHGLGS
HHHHHCCCCCCCCCC
48.35-
1032PhosphorylationKEGHGLGSLGKGIRE
CCCCCCCCCCCCCCC
38.7025159151
1035AcetylationHGLGSLGKGIREPVS
CCCCCCCCCCCCCCC
57.3625953088
1035UbiquitinationHGLGSLGKGIREPVS
CCCCCCCCCCCCCCC
57.36-
1042PhosphorylationKGIREPVSVGTPSEG
CCCCCCCCCCCCCCC
26.0827732954
1045PhosphorylationREPVSVGTPSEGEGL
CCCCCCCCCCCCCCC
22.8327732954
1047PhosphorylationPVSVGTPSEGEGLGA
CCCCCCCCCCCCCCC
59.0628985074

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
7TPhosphorylationKinaseATRQ13535
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SUGP2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SUGP2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TIM10_HUMANTIMM10physical
22939629
T10B_HUMANTIMM10Bphysical
22939629
T126B_HUMANTMEM126Bphysical
22939629

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of SUGP2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277 AND SER-773, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-275; SER-277 ANDSER-315, AND MASS SPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-7 AND SER-940, AND MASSSPECTROMETRY.
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277, AND MASSSPECTROMETRY.

TOP